-
1
المؤلفون: Sheila Mansouri, Kelly Burrell, Alenoush Vartanian, Mark R. Wilson, Shahrzad Jalali, Peter D. Tonge, Amir Alamsahebpour, Michael S. Taccone, Kenneth Aldape, Sameer Agnihotri, Brian Golbourn, Gelareh Zadeh
المصدر: Oncotarget
مصطلحات موضوعية: Male, 0301 basic medicine, Cell signaling, MAP Kinase Signaling System, DNA damage, Dacarbazine, medicine.medical_treatment, Mice, SCID, 03 medical and health sciences, Mice, Inbred NOD, Cell Line, Tumor, Hexokinase, Temozolomide, medicine, Animals, Humans, cell signaling, Antineoplastic Agents, Alkylating, Cell Proliferation, Chemotherapy, Gene knockdown, Brain Neoplasms, business.industry, Cell growth, glioblastoma, Cancer, Chemoradiotherapy, medicine.disease, Xenograft Model Antitumor Assays, HEK293 Cells, 030104 developmental biology, Oncology, Immunology, Cancer research, novel treatments, RNA Interference, business, metabolism, DNA Damage, Research Paper, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538195c280304daaf7a6e99b15f920af
https://doi.org/10.18632/oncotarget.11680